Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United Kingdom

PURPOSE: To compare the risk of acute kidney injury (AKI) among users of rivaroxaban vs warfarin. PATIENTS AND METHODS: We identified two cohorts of patients with non-valvular atrial fibrillation (NVAF) who initiated rivaroxaban (15/20 mg/day, N = 6436) or warfarin (N = 7129) excluding those without...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Pérez, Antonio, Balabanova, Yanina, Sáez, María E, Brobert, Gunnar, García Rodríguez, Luis A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637331/
https://www.ncbi.nlm.nih.gov/pubmed/36349147
http://dx.doi.org/10.2147/CLEP.S383996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637331/
https://www.ncbi.nlm.nih.gov/pubmed/36349147
http://dx.doi.org/10.2147/CLEP.S383996

Ejemplares similares